A Phase 3, Multi-center, Randomized Study Evaluating Efficacy of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-Invasive Urothelial Carcinoma (MIBC) of the Bladder who are not Receiving Radical Cyst

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/00 → 1/1/00

Funding

  • Janssen Pharmaceutical Research and Development ( Award # ): $16,625.00